Medicon Hellas S.A.

AT:MEDIC Greece Drug Manufacturers - Specialty & Generic
Market Cap
$11.07 Million
€10.78 Million EUR
Market Cap Rank
#43543 Global
#119 in Greece
Share Price
€2.44
Change (1 day)
-0.41%
52-Week Range
€1.96 - €2.87
All Time High
€5.07
About

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It al… Read more

Medicon Hellas S.A. - Asset Resilience Ratio

Latest as of December 2022: 32.11%

Medicon Hellas S.A. (MEDIC) has an Asset Resilience Ratio of 32.11% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
€10.21 Million
Cash + Short-term Investments
Total Assets
€31.81 Million
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2022)

This chart shows how Medicon Hellas S.A.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Medicon Hellas S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €10.21 Million 32.11%
Short-term Investments €0.00 0%
Total Liquid Assets €10.21 Million 32.11%

Asset Resilience Insights

  • Very High Liquidity: Medicon Hellas S.A. maintains exceptional liquid asset reserves at 32.11% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Medicon Hellas S.A. Industry Peers by Asset Resilience Ratio

Compare Medicon Hellas S.A.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Lavipharm S.A
AT:LAVI
Drug Manufacturers - Specialty & Generic 0.00%
Tsumura & Co
MU:TSUA
Drug Manufacturers - Specialty & Generic 0.14%

Annual Asset Resilience Ratio for Medicon Hellas S.A. (2020–2022)

The table below shows the annual Asset Resilience Ratio data for Medicon Hellas S.A..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 32.11% €10.21 Million €31.81 Million -1.11pp
2021-12-31 33.21% €10.36 Million €31.19 Million +8.03pp
2020-12-31 25.18% €7.20 Million €28.61 Million --
pp = percentage points